MDT logo

Medtronic plc. (MDT)

$99.49

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on MDT

Market cap

$127.55B

EPS

3.69

P/E ratio

26.8

Price to sales

3.67

Dividend yield

2.855%

Beta

0.712759

Price on MDT

Previous close

$100.88

Today's open

$100.92

Day's range

$99.12 - $102.51

52 week range

$79.55 - $106.33

Profile about MDT

CEO

Geoffrey S. Martha

Employees

95000

Headquarters

Galway,

Exchange

New York Stock Exchange

Shares outstanding

1.28B

Issue type

Common Stock

MDT industries and sectors

Healthcare

Medical Equipment & Supplies

News on MDT

3 Dividend Stocks to Double Up On Right Now

Microsoft has been investing heavily in artificial intelligence (AI). Medtronic is rolling out new medical devices and has a long dividend track record.

news source

The Motley Fool • 18 hours ago

news preview

How To Earn $500 A Month From Medtronic Stock Ahead Of Q3 Earnings

Medtronic plc (NYSE: MDT) will release earnings for its third quarter before the opening bell on Tuesday, Feb. 17.

news source

Benzinga • Feb 13, 2026

news preview

Medtronic receives FDA clearance for Stealth AXiS™ surgical system, first integrated planning, navigation and robotics platform for spine surgery

GALWAY, Ireland, Feb. 13, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS™ surgical system, a next-generation platform that brings planning, navigation, and robotics together into a single, intelligent system for spine surgery. The Stealth AXiS™ system is cleared for spine procedures in the United States, with an underlying architecture designed to support future cranial and ENT applications, pending 510(k) clearance.

news source

PRNewsWire • Feb 13, 2026

news preview

Medtronic: Navigating Tariffs And Chinese VBP Challenges

Medtronic delivered solid Q2 results with beats on revenue and EPS, but now trades at a 5% premium to fair value. Segment growth was led by Cardiovascular and Diabetes, though headwinds from Chinese procurement, tariffs, and regulatory risks persist. FY26 guidance was modestly raised, but forward EPS growth is just 2.5% and revenue guidance remains below consensus.

news source

Seeking Alpha • Feb 13, 2026

news preview

These 32 favorite stocks signal the bull market is running on fumes

The S&P 500 sectors that top investment newsletters currently like most are strongest at market peaks.

news source

Market Watch • Feb 12, 2026

news preview

Medtronic to announce financial results for its third quarter of fiscal year 2026

GALWAY, Ireland, Feb. 11, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, February 17, 2026, for its third quarter of fiscal year 2026, which ended on Friday, January 23, 2026. A news release containing summary financial information will be issued at approximately 5:45 a.m.

news source

PRNewsWire • Feb 11, 2026

news preview

Ahead of Medtronic (MDT) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Medtronic (MDT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended January 2026.

news source

Zacks Investment Research • Feb 11, 2026

news preview

Strength in Cardiovascular Unit Likely to Lift MDT's Q3 Performance

Medtronic's Q3 outlook hinges on strong Cardiovascular momentum, with revenues projected to be up 7.3% year over year despite softer EPS.

news source

Zacks Investment Research • Feb 9, 2026

news preview

Medtronic (MDT) Stock Dips While Market Gains: Key Facts

Medtronic (MDT) concluded the recent trading session at $101.72, signifying a -1.15% move from its prior day's close.

news source

Zacks Investment Research • Feb 9, 2026

news preview

What is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill.

High-yielding dividend growth stocks tend to deliver the best long-term performance. Johnson & Johnson and Medtronic both offer dividend yields that are well above the S&P 500.

news source

The Motley Fool • Feb 8, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Medtronic plc.

Open an M1 investment account to buy and sell Medtronic plc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in MDT on M1